Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| Reliance Pharma Fund - Direct Plan Growth Plan - Growth Option | 137.3 | 9.23% | 4.31% | -2.30% | -9.31% | -11.81% | 14.44% | 2017-09-22 |
| Reliance Pharma Fund-Growth Plan-Growth Option | 132.2 | 9.13% | 4.05% | -2.74% | -10.09% | -13.39% | 11.56% | 2017-09-22 |
| UTI Pharma & Healthcare Fund-Growth Option- Direct | 87.3 | 5.30% | 1.18% | -6.03% | -11.84% | -13.68% | 9.10% | 2017-09-22 |
| UTI Pharma & Healthcare Fund-Income Option-Direct | 67.4 | 5.28% | 1.17% | -6.05% | -11.85% | -13.69% | 9.09% | 2017-09-22 |
| UTI Pharma & Healthcare Fund-Income Option | 64.8 | 5.20% | 0.92% | -6.47% | -12.61% | -15.26% | 6.20% | 2017-09-22 |
| UTI Pharma & Healthcare Fund-Growth Option | 83.8 | 5.20% | 0.92% | -6.47% | -12.62% | -15.26% | 6.18% | 2017-09-22 |
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 8.6 | 5.14% | -2.72% | -6.83% | -13.06% | NA | NA | 2017-09-22 |
| SBI PHARMA - DIRECT PLAN -GROWTH | 131.7 | 6.25% | 1.56% | -8.70% | -14.39% | -13.73% | 22.11% | 2017-09-22 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 8.3 | 5.04% | -3.25% | -7.64% | -14.46% | NA | NA | 2017-09-22 |
| SBI PHARMA - REGULAR PLAN -GROWTH | 125.3 | 6.14% | 1.25% | -9.24% | -15.38% | -15.82% | 17.69% | 2017-09-22 |